Law360, New York (September 01, 2006, 12:00 AM ET) -- In a significant victory for Bristol-Myers Squibb & Co. and Sanofi-Aventis Corp., a federal judge has granted the pharmaceuticals a preliminary injunction, ordering Apotex Corp. to cease selling its generic version of the blood thinner Plavix.
The court also ordered Bristol-Myers and Sanofi to post a $400 million bond to Apotex to provide security in the event that the court later concludes that the injunction should not have been issued.
The injunction will be in effect until the pending patent infringement lawsuit is resolved. A trial...
Court Grants Injunction Barring Generic Plavix
To view the full article, take a free trial now.
